Most cited papers in Ginkgo biloba and Cashew Applications
What are the most cited papers in Ginkgo biloba and Cashew Applications?
The most cited paper in Ginkgo biloba and Cashew Applications is "Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study" (M.G.L Hertog, Edith J. M. Feskens, Daan Kromhout et al., 1993), with 4,357 citations. Next come "Clinical diagnostic criteria for dementia associated with Parkinson's disease" (3,081) and "Antioxidant Activity and Phenolic Compounds in Selected Herbs" (2,885).
Showing 50 of 100 papers. Every paper with more than 448 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study M.G.L Hertog, Edith J. M. Feskens, Daan Kromhout et al. · The Lancet | Oct 1993 | 4,357 |
| 2 | Clinical diagnostic criteria for dementia associated with Parkinson's disease Murat Emre et al. · Movement Disorders | 31 May 2007 | 3,081 |
| 3 | Antioxidant Activity and Phenolic Compounds in Selected Herbs Wei Zheng, Shiow Y. Wang · Journal of Agricultural and Food Chemistry | 28 Sep 2001 | 2,885 |
| 4 | Dietary (Poly)phenolics in Human Health: Structures, Bioavailability, and Evidence of Protective Effects Against Chronic Diseases Daniele Del Rio, Ana Rodriguez‐Mateos, Jeremy P. E. Spencer et al. · Antioxidants and Redox Signaling | 15 Jul 2012 | 2,587 |
| 5 | Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines Irene Litvan, Jennifer G. Goldman, Alexander I. Tröster et al. · Movement Disorders | 24 Jan 2012 | 2,583 |
| 6 | Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030 Earl Ray Dorsey, Radu Constantinescu, James P. Thompson et al. · Neurology | 3 Nov 2006 | 2,508 |
| 7 | Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment Ronald Petersen, Ronald G. Thomas, Michael J Grundman et al. · New England Journal of Medicine | 14 Apr 2005 | 1,863 |
| 8 | The Hawthorne Effect: a randomised, controlled trial Rob McCarney, James P. Warner, Steve Iliffe et al. · BMC Medical Research Methodology | 3 Jul 2007 | 1,749 |
| 9 | EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers Dagmar E. Ehrnhoefer, Jan Bieschke, Annett Boeddrich et al. · Nature Structural & Molecular Biology | 30 May 2008 | 1,448 |
| 10 | Folate, Vitamin B12, and Serum Total Homocysteine Levels in Confirmed Alzheimer Disease Robert Clarke, A. David Smith, Kim A. Jobst et al. · Archives of Neurology | Nov 1998 | 1,418 |
| 11 | A Review on the Dietary Flavonoid Kaempferol José Manuel Calderón‐Montaño, Estefanía Burgos‐Morón, Concepción Pérez‐Guerrero et al. · Mini-Reviews in Medicinal Chemistry | Apr 2011 | 1,387 |
| 12 | Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention Chengxuan Qiu, Miia Kivipelto, Eva von Strauss · Dialogues in Clinical Neuroscience | 30 Jun 2009 | 1,284 |
| 13 | Oxidative stress and Alzheimer disease Yves Christen · American Journal of Clinical Nutrition | Feb 2000 | 1,169 |
| 14 | Alzheimer's Disease Jeffrey L. Cummings · New England Journal of Medicine | 30 Jun 2004 | 1,134 |
| 15 | An Overview of Plant Phenolic Compounds and Their Importance in Human Nutrition and Management of Type 2 Diabetes Derong Lin, Mengshi Xiao, Jingjing Zhao et al. · Molecules | 15 Oct 2016 | 1,094 |
| 16 | Epidemiology of Constipation in North America: A Systematic Review Peter Higgins, John F. Johanson · The American Journal of Gastroenterology | Apr 2004 | 1,087 |
| 17 | The Nitric Oxide-Scavenging Properties of Ginkgo Biloba Extract EGb 761 Lucia Marcocci, John J. Maguire, Marie Therese Droy-Lefaix et al. · Biochemical and Biophysical Research Communications | Jun 1994 | 1,049 |
| 18 | Cognitive decline in Parkinson disease Dag Aarsland, Byron Creese, Marios Politis et al. · Nature Reviews Neurology | 3 Mar 2017 | 1,036 |
| 19 | EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity Jan Bieschke, Jenny Russ, Ralf P. Friedrich et al. · Proceedings of the National Academy of Sciences | 12 Apr 2010 | 1,022 |
| 20 | Beneficial effects of green tea: A literature review Sabu Mandumpal Chacko, Priya T Thambi, Ramadasan Kuttan et al. · Chinese Medicine | 2010 | 992 |
| 21 | Reversals of Age-Related Declines in Neuronal Signal Transduction, Cognitive, and Motor Behavioral Deficits with Blueberry, Spinach, or Strawberry Dietary Supplementation James A. Joseph, Barbara Shukitt‐Hale, Natalia A. Denisova et al. · Journal of Neuroscience | 15 Sep 1999 | 981 |
| 22 | A Review on Kombucha Tea—Microbiology, Composition, Fermentation, Beneficial Effects, Toxicity, and Tea Fungus R. Jayabalan, Radomir V. Malbaša, Eva Lončar et al. · Comprehensive Reviews in Food Science and Food Safety | 21 Jun 2014 | 940 |
| 23 | The Prevention of Dementia With Antihypertensive Treatment New Evidence From the Systolic Hypertension in Europe (Syst-Eur) Study Françoise Forette · Archives of Internal Medicine | 14 Oct 2002 | 897 |
| 24 | Dementia in China: epidemiology, clinical management, and research advances Longfei Jia, Meina Quan, Yue Fu et al. · The Lancet Neurology | 4 Sep 2019 | 892 |
| 25 | Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease Victor L. Villemagne, Kerryn Elizabeth Pike, Gaël Chételat et al. · Annals of Neurology | 2011 | 839 |
| 26 | A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease Miguel Ángel Hernán, Bahi Takkouche, Francisco Caamaño‐Isorna et al. · Annals of Neurology | 29 May 2002 | 822 |
| 27 | Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial A. David Smith, Stephen M. Smith, Celeste A. de Jager et al. · PLoS ONE | 8 Sep 2010 | 821 |
| 28 | Tannins: classification and definition. Karamali Khanbabaee, Teunis van Ree · Natural Product Reports | 18 Sep 2001 | 811 |
| 29 | Lewy Bodies in Alzheimer's Disease: A Neuropathological Review of 145 Cases Using α‐Synuclein Immunohistochemistry Ronald L. Hamilton · Brain Pathology | Jul 2000 | 768 |
| 30 | Green Tea Consumption and Mortality Due to Cardiovascular Disease, Cancer, and All Causes in Japan Shinichi Kuriyama, Taichi Shimazu, Kaori Ohmori et al. · JAMA | 12 Sep 2006 | 767 |
| 31 | Interactions Between Herbal Medicines and Prescribed Drugs Angelo Antonio Izzo, Edzard Ernst · Drugs | 2001 | 718 |
| 32 | Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction Thomas G. Beach, Charles H. Adler, Lih‐Fen Lue et al. · Acta Neuropathologica | 27 Apr 2009 | 717 |
| 33 | Are men at greater risk for Parkinson's disease than women? G. Frederick Wooten · Journal of Neurology Neurosurgery & Psychiatry | 16 Mar 2004 | 710 |
| 34 | The Role of Catechins in Cellular Responses to Oxidative Stress Jurga Bernatonienė, Dalia M. Kopustinskienė · Molecules | 20 Apr 2018 | 705 |
| 35 | Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: A review of their intracellular targets Charles Ramassamy · European Journal of Pharmacology | 18 Jun 2006 | 686 |
| 36 | Dementia associated with Parkinson's disease Murat Emre · The Lancet Neurology | 26 Mar 2003 | 685 |
| 37 | Ginkgo biloba for Prevention of Dementia A Randomized Controlled Trial Steven T. DeKosky · JAMA | 18 Nov 2008 | 670 |
| 38 | p ‐Coumaric acid and its conjugates: dietary sources, pharmacokinetic properties and biological activities Kehan Pei, Juanying Ou, Junqing Huang et al. · Journal of the Science of Food and Agriculture | 22 Dec 2015 | 651 |
| 39 | Intake of flavonoids and risk of dementia Daniel Commenges, Virginie Scotet, Samantha Renaud et al. · European Journal of Epidemiology | Apr 2000 | 635 |
| 40 | Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop Ian Grant McKeith · Journal of Alzheimer s Disease | 27 Jul 2006 | 634 |
| 41 | Dementia with Lewy bodies Ian Grant McKeith, Jacobo E Mintzer, Dag Aarsland et al. · The Lancet Neurology | 18 Dec 2003 | 620 |
| 42 | Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients. Jean Marie Bourre · PubMed | 23 Jan 2007 | 618 |
| 43 | Herbal Medicine in the United States: Review of Efficacy, Safety, and Regulation Stephen Bent · Journal of General Internal Medicine | 15 Apr 2008 | 617 |
| 44 | Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe Adam J. Harding, Gerald Anthony Broe, Glenda Margaret Halliday · Brain | Feb 2002 | 617 |
| 45 | A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group P L Le Bars · JAMA | 22 Oct 1997 | 607 |
| 46 | Mechanisms of antidiabetic effects of flavonoid rutin Ahmad Ghorbani · Biomedicine & Pharmacotherapy | 12 Oct 2017 | 603 |
| 47 | Rutin: A review on extraction, identification and purification methods, biological activities and approaches to enhance its bioavailability Beatriz Gullón, Thelmo Alejandro Lu-Chau, Marı́a Teresa Moreira et al. · Trends in Food Science & Technology | 11 Jul 2017 | 603 |
| 48 | Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy Bradley F. Boeve, Michael H. Silber, Tanis J. Ferman et al. · Movement Disorders | 15 Jun 2001 | 601 |
| 49 | Reporting Randomized, Controlled Trials of Herbal Interventions: An Elaborated CONSORT Statement Joel Joseph Gagnier, Heather Shirley Boon, Paula A. Rochon et al. · Annals of Internal Medicine | 7 Mar 2006 | 601 |
| 50 | Cell Biology and Pathophysiology of α-Synuclein Jacqueline Burré, Manu Sharma, Thomas C. Südhof · Cold Spring Harbor Perspectives in Medicine | 20 Jan 2017 | 596 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.